Tag: FTC pharmaceutical competition
Patent Litigation: How Authorized Generics Undermine Generic Competition
Nov, 27 2025
Authorized generics let brand drug makers launch their own cheaper versions right when independent generics enter the market, undermining price competition and reducing incentives for patent challenges. This practice hurts patients and generic manufacturers - and regulators are fighting back.
Read Article→Categories
online pharmacy
medication safety
generic drugs
side effects
pharmacovigilance
Hatch-Waxman Act
medication side effects
GoodRx coupons
dosage
counterfeit drugs
patent litigation
insomnia treatment
generic substitution
drug interactions
medication adherence
drug safety
bioequivalence
benefits
pharmacy alternatives
pain relief